ImmuCell Corp (ICCC):企業の財務・戦略的SWOT分析

◆英語タイトル:ImmuCell Corp (ICCC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME317FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

ImmuCell Corp (ICCC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ImmuCell Corp (Immucell) is an animal health biotechnology company. It develops, manufactures and markets products that improve animal health and productivity in the beef cattle and dairy industry. The company’s flagship product includes First Defense, a bovine coronavirus-escherichia coli antibody and its product line extension, First Defense Tri-Shield. First Defense is the United States Department of Agriculture (USDA)- licensed antibodies which provide Immediate Immunity to the calves against corona virus and E.coli K99. It also offers California Mastitis Test Kit for early detection of mastitis. Immucell is developing Re – Tain, an intramammary infusion product for the treatment of subclinical mastitis in lactating dairy cows. The company sells its products through distributors and dairy producers. ImmuCell is headquartered in Portland, Maine, the US.

ImmuCell Corp Key Recent Developments

Dec 15,2020: ImmuCell announces restructuring of its bank debt
Nov 12,2020: ImmuCell announces unaudited financial results for the third quarter ended September 30, 2020
Oct 06,2020: ImmuCell announces preliminary, unaudited sales results for the quarter ended September 30, 2020
Aug 12,2020: ImmuCell announces unaudited financial results for the second quarter ended June 30, 2020
Jul 07,2020: ImmuCell announces preliminary, unaudited sales results for the second quarter ended June 30, 2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
ImmuCell Corp – Key Facts
ImmuCell Corp – Key Employees
ImmuCell Corp – Key Employee Biographies
ImmuCell Corp – Major Products and Services
ImmuCell Corp – History
ImmuCell Corp – Company Statement
ImmuCell Corp – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
ImmuCell Corp – Business Description
Product Category: First Defense Product Line
Performance
Product Category: Other
Performance
Product Category: Other Animal Health
Performance
Geographical Segment: Other
Performance
Geographical Segment: United States
Performance
ImmuCell Corp – SWOT Analysis
SWOT Analysis – Overview
ImmuCell Corp – Strengths
ImmuCell Corp – Weaknesses
ImmuCell Corp – Opportunities
ImmuCell Corp – Threats
ImmuCell Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
ImmuCell Corp, Recent Deals Summary
Section 4 – Company’s Recent Developments
Dec 15, 2020: ImmuCell announces restructuring of its bank debt
Nov 12, 2020: ImmuCell announces unaudited financial results for the third quarter ended September 30, 2020
Oct 06, 2020: ImmuCell announces preliminary, unaudited sales results for the quarter ended September 30, 2020
Aug 12, 2020: ImmuCell announces unaudited financial results for the second quarter ended June 30, 2020
Jul 07, 2020: ImmuCell announces preliminary, unaudited sales results for the second quarter ended June 30, 2020
May 13, 2020: ImmuCell announces unaudited financial results for the first quarter ended March 31, 2020
Jan 21, 2020: ImmuCell announces preliminary, unaudited product sales results for the year ended December 31, 2019
Nov 11, 2019: ImmuCell announces unaudited financial results for third quarter of 2019
May 13, 2019: ImmuCell announces unaudited financial results for first quarter of 2019
Feb 13, 2019: ImmuCell announces preliminary financial results for fourth quarter and full year 2018
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
ImmuCell Corp, Key Facts
ImmuCell Corp, Key Employees
ImmuCell Corp, Key Employee Biographies
ImmuCell Corp, Major Products and Services
ImmuCell Corp, History
ImmuCell Corp, Key Competitors
ImmuCell Corp, Ratios based on current share price
ImmuCell Corp, Annual Ratios
ImmuCell Corp, Annual Ratios (Cont...1)
ImmuCell Corp, Annual Ratios (Cont...2)
ImmuCell Corp, Interim Ratios
ImmuCell Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[ImmuCell Corp (ICCC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Al Jaber Group
    Al Jaber Group - Strategy, SWOT and Corporate Finance Report Summary Al Jaber Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Reach PLC:企業の戦略・SWOT・財務分析
    Reach PLC - Strategy, SWOT and Corporate Finance Report Summary Reach PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Neoleukin Therapeutics Inc (NLTX):企業の財務・戦略的SWOT分析
    Summary Neoleukin Therapeutics Inc (Neoleukin), formely Aquinox Pharmaceuticals Inc is a biopharmaceutical company develops next generation immunotherapies to treat immunological disorders. The company's lead drug candidate NL-201 is a combined IL-2 and IL-15 protein therapeutic used as an agonist i …
  • Boule Diagnostics AB (BOUL):企業の財務・戦略的SWOT分析
    Summary Boule Diagnostics AB (Boule) is a medical device company that offers hematology diagnostic solutions. The company provides systems and consumer products for complete blood counts to non-institutional healthcare. It offers products such as blood cell counter and instruments, reagents, calibra …
  • Program for Appropriate Technology in Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Program for Appropriate Technology in Health (PATH) is a non-profit organization that improves health in women and children. The organization offers vaccines, drugs, diagnostics, devices, system and service innovations, and digital health solutions. It develops diagnostics for HIV and other …
  • QAD Inc (QADA):企業の財務・戦略的SWOT分析
    QAD Inc (QADA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Polimex-Mostostal SA (PXM):企業の財務・戦略的SWOT分析
    Polimex-Mostostal SA (PXM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Oneok Inc (OKE):企業の財務・戦略的SWOT分析
    Oneok Inc (OKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • EnBW Energie Baden-Wurttemberg AG:発電所・企業SWOT分析
    EnBW Energie Baden-Wurttemberg AG - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • OnKure Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OnKure Inc (OnKure) is a drug developer that discovers and develops epigenetic therapies for the treatment of cancer. The company offers production of specific histone deacetylases inhibitors. Its lead product candidate ONK102 significantly reduces the growth rate of tumors in hematological …
  • Hubbell Inc (HUBB):企業の財務・戦略的SWOT分析
    Hubbell Inc (HUBB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Stanwell Corp Ltd:企業の戦略的SWOT分析
    Stanwell Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Votorantim SA:企業の戦略的SWOT分析
    Votorantim SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Singapore Technologies Engineering Ltd (S63):企業の財務・戦略的SWOT分析
    Singapore Technologies Engineering Ltd (S63) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • OMRON Corporation:企業の戦略・SWOT・財務分析
    OMRON Corporation - Strategy, SWOT and Corporate Finance Report Summary OMRON Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • CryoPort Inc (CYRX)-製薬・医療分野:企業M&A・提携分析
    Summary Cryoport Inc (Cryoport) is a provider of cold chain logistics solutions for temperature-sensitive biological materials to the life science industries. It offers liquid nitrogen dry vapor shippers with advanced logistics management platform called Cryoportal, which provides credentials relate …
  • First Republic Bank:企業の戦略・SWOT・財務情報
    First Republic Bank - Strategy, SWOT and Corporate Finance Report Summary First Republic Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Korea Petrochemical Ind. Co Ltd (006650):企業の財務・戦略的SWOT分析
    Summary Korea Petrochemical Ind. Co Ltd (KPICL) is a chemical company that manufactures and markets petrochemical products. The company provides products such as olefins, aromatics, polypropylene, EO and EG, PP and HDPE. It provides olefins products such as ethylene, propylene, butene, butane, isobu …
  • Colefax Group Plc:企業の戦略・SWOT・財務情報
    Colefax Group Plc - Strategy, SWOT and Corporate Finance Report Summary Colefax Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Krung Thai Bank PCL:企業の戦略・SWOT・財務分析
    Krung Thai Bank PCL - Strategy, SWOT and Corporate Finance Report Summary Krung Thai Bank PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆